Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
AFT Pharmaceuticals (AFT NZ)
Watchlist
49
Analysis
Health Care
•
New Zealand
AFT Pharmaceuticals Limited develops, licenses, and sells pharmaceutical products. The Company offers medicines for allergy, cough, cold, and flu, eye care, pain management, and laxatives. AFT Pharmaceuticals serves customers worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
AFT Pharmaceuticals
•
02 Sep 2022 16:16
•
Issuer-paid
AFT Pharmaceuticals - Collaboration for developing birthmark medicine
AFT Pharmaceuticals has announced a collaboration and in-licensing agreement with Massey Ventures (the commercialisation arm of Massey University,...
Edison Investment Research
Follow
660 Views
Share
bullish
•
Aft Pharmaceuticals
•
28 Jul 2022 16:22
•
Issuer-paid
AFT Pharmaceuticals - Pascomer falls short of FDA mandated threshold
AFT Pharmaceuticals announced that its Pascomer Phase II clinical trial has failed to meet its primary endpoint of a two-point improvement on the...
Edison Investment Research
Follow
661 Views
Share
bullish
•
Aft Pharmaceuticals
•
08 Jul 2022 16:02
•
Issuer-paid
AFT Pharmaceuticals - Expanding reach into China
AFT Pharmaceuticals has announced the online launch of a wider range of its over-the-counter (OTC) medicines in China following registration under...
Edison Investment Research
Follow
674 Views
Share
bullish
•
Aft Pharmaceuticals
•
06 Jul 2022 15:34
•
Issuer-paid
AFT Pharmaceuticals - Maxigesic IV hits a roadblock in the US
In an unexpected development, AFT Pharmaceuticals (AFT) has announced that it has received a complete response letter (CRL) from the United States...
Edison Investment Research
Follow
673 Views
Share
bullish
•
Aft Pharmaceuticals
•
17 Jun 2022 00:19
•
Issuer-paid
AFT Pharmaceuticals - Re-acceleration leveraging its platform
Overcoming COVID-19 headwinds, AFT Pharmaceuticals reported strong FY22 year results, largely driven by management’s ability to leverage its broad...
Edison Investment Research
Follow
679 Views
Share
First
Previous
5
6
7
8
9
10
11
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x